2025 AAD Annual Meeting: Industry Product Sessions

Discover the latest industry insights at the 2025 Annual Meeting through engaging educational and product-focused sessions. These presentations give exhibiting companies a platform to unveil groundbreaking research, showcase product innovations, perform live demonstrations, and highlight their newest offerings.
These sessions are solely promotional and are not eligible for CME credit.
Session schedule
Friday, March 7, 2025 | Theater 1 | Booth 426 |
---|
10:30 a.m. - 11:15 a.m.
Presented by: Obagi Medical
Pairing Skin Care with Procedures to Enhance Results and Minimize Complications
This lecture addresses managing complications in energy-based device procedures, emphasizing skincare regimens to minimize risks, enhance results, and improve outcomes for a diverse range of patients.

11:15 a.m. - 12:00 p.m.
Presented by: Amgen and Kyowa Kirin
Discover the OX40 Receptor: A New Frontier in Moderate-to-Severe Atopic Dermatitis Heterogeneity and Chronicity
Join us in exploring new perspectives on how OX40 receptor-expressing pathogenic T-cells amplify inflammatory mechanisms beyond type 2 inflammation and drive disease heterogeneity and chronicity in atopic dermatitis.

1:30 p.m. - 2:15 p.m.
Presented by: Sanofi and Regeneron
Expert Master Chats: Managing Challenging Skin Conditions
Join the conversation as two leading experts walk through their approach for assessment, treatment and management of two challenging patient case.

Friday, March 7, 2025 | Theater 2 | Booth 444 |
---|
11:15 a.m. - 12:00 p.m.
Presented by: Eli Lilly
Experience EBGLYSS™ (lebrikizumab-lbkz): Consider This Option for Your Patients
Join us as a clinician will discuss the efficacy and safety of EBGLYSS. This program features data on efficacy, safety, and how to get patients started on EBGLYSS.

12:45 p.m. - 1:30 p.m.
Presented by: Eli Lilly
A Product Theater for Zepbound® (tirzepatide) injection including an Affordability Solution for Taltz® (ixekizumab) Patients
Join us for this Lilly event! Please see Full Prescribing Information for Zepbound including Boxed Warning and Medication Guide at the product theater or on www.zepbound.lilly.com.

2:15 pm. - 3:00 p.m.
Presented by: Eli Lilly
Obesity-Related Inflammation & Psoriasis: A Conversation on the Interplay and What You Need to Know
Examine the relationship between psoriasis, obesity, and inflammation. Explore the epidemiology and burden of psoriasis and obesity. Discuss challenges in managing these patients and practical ways to provide holistic care.

Saturday, March 8, 2025 | Theater 1 | Booth 426 |
---|
10:30 a.m. - 11:15 a.m.
Presented by: Lumenis
Unlocking New Possibilities in Hair Loss Treatment
Explore the future of hair loss treatment, covering emerging trends and breakthrough technologies. Learn about FoLix, the only FDA-cleared fractional laser for hair loss.

12:00 p.m. - 12:45 p.m.
Presented by: Vaim Global
The Emergence of a New Biostimulator: Understanding PDLLA
Discover world's first patented Poly-D,L-Lactic Acid biostimulator combined with hyaluronic acid for long-term collagen production. This session focuses on the science and clinical applications behind its results.

1:30 p.m. - 2:15 p.m.
Presented by: RoC Skincare
RoC 35: The First Clinically Proven Skin Rejuvenating Protocol Tested by 35 Clinics
A breakthrough skincare regimen to help women look as young as they feel, reducing skin age assessment by 9.6 years in just 90 days.

Saturday, March 8, 2025 | Theater 2 | Booth 444 |
---|
11:15 a.m. - 12:00 p.m.
Presented by: ISDIN
The Future of Sunscreens: Introducing the concept of Biological Photoprotection
Discuss the potential of biological photoprotection and innovative technologies to shape the future of sunscreens, assessing their role in enhancing protection and promoting healthier skin.

12:45 p.m. - 1:30 p.m.
Presented by: Phothera
Phototherapy: The Clear Choice for Clearer Skin
Where we will explore phototherapy’s proven benefits, supported by LITE Study evidence, and its role in effective, accessible dermatologic care.

Sunday, March 9, 2025 | Theater 1 | Booth 426 |
---|
12:00 p.m. - 12:45 p.m.
Presented by: Galderma
Targeting the IL-31 Neuroimmune Pathway: Transforming Itch and Inflammation Outcomes
This presentation delves into the crucial need to address the role of neuroimmune interactions with a focus on the impact of IL-31 and how a targeted treatment impacts patient outcomes.
